The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials
Annette Rid, Marc Lipsitch, Franklin G. Miller
Abstract
Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines
Topics & Concepts
MedicineAuthorizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PlaceboCoronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakClinical trialIntensive care medicineAlternative medicineInternal medicineInfectious disease (medical specialty)PathologyOutbreakComputer securityComputer scienceDiseaseEthics in medical practiceEthics in Clinical ResearchClinical Reasoning and Diagnostic Skills